WSES consensus conference guidelines: Monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 hours by E. Picetti et al.
REVIEW Open Access
WSES consensus conference guidelines:
monitoring and management of severe
adult traumatic brain injury patients with
polytrauma in the first 24 hours
Edoardo Picetti1*, Sandra Rossi1, Fikri M. Abu-Zidan2, Luca Ansaloni3, Rocco Armonda4, Gian Luca Baiocchi5,
Miklosh Bala6, Zsolt J. Balogh7, Maurizio Berardino8, Walter L. Biffl9, Pierre Bouzat10, Andras Buki11,12,
Marco Ceresoli13,14, Randall M. Chesnut15, Osvaldo Chiara16, Giuseppe Citerio14,17, Federico Coccolini3,
Raul Coimbra18, Salomone Di Saverio19, Gustavo P. Fraga20, Deepak Gupta21, Raimund Helbok22,
Peter J. Hutchinson23,24, Andrew W. Kirkpatrick25, Takahiro Kinoshita26, Yoram Kluger27, Ari Leppaniemi28,
Andrew I. R. Maas29, Ronald V. Maier30, Francesco Minardi1, Ernest E. Moore31, John A. Myburgh32,
David O. Okonkwo33, Yasuhiro Otomo34, Sandro Rizoli35, Andres M. Rubiano36,37, Juan Sahuquillo38,
Massimo Sartelli39, Thomas M. Scalea40, Franco Servadei41, Philip F. Stahel42, Nino Stocchetti43,44,
Fabio S. Taccone45, Tommaso Tonetti1, George Velmahos46, Dieter Weber47 and Fausto Catena48
Abstract
The acute phase management of patients with severe traumatic brain injury (TBI) and polytrauma represents a
major challenge. Guidelines for the care of these complex patients are lacking, and worldwide variability in clinical
practice has been documented in recent studies. Consequently, the World Society of Emergency Surgery (WSES)
decided to organize an international consensus conference regarding the monitoring and management of severe
adult TBI polytrauma patients during the first 24 hours after injury. A modified Delphi approach was adopted, with
an agreement cut-off of 70%. Forty experts in this field (emergency surgeons, neurosurgeons, and intensivists)
participated in the online consensus process. Sixteen recommendations were generated, with the aim of promoting
rational care in this difficult setting.
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Introduction
Traumatic brain injury (TBI), both isolated and in combin-
ation with extra-cranial lesions, is a global health problem
associated with high mortality and disability [1, 2]. In
addition, post-traumatic bleeding is a leading cause of pre-
ventable death among injured patients [3–5]. A multicenter
observational study, involving 1536 trauma patients, identi-
fied exsanguination as the most frequent cause of early
death [5]. The same study, however, found TBI as the most
common cause of delayed mortality and disability [5].
Therefore, the combination of brain damage and extra-
cranial injuries, causing bleeding, shock, and arterial
hypotension, is especially challenging. On the one hand,
bleeding can be rapidly life-threatening and has to be
corrected promptly; in this regard, various strategies, often
including “permissive arterial hypotension”, have been pro-
posed [6–10]. On the other hand, arterial hypotension may
exacerbate cerebral secondary damage and is associated
with further worsening of the outcome [11].
A recent international survey revealed great variability
in clinical practice during the acute phase management
of polytrauma patients with TBI [12]. Moreover, guide-
lines regarding optimal monitoring and management
strategies in this setting are lacking [10, 13]. Considering
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the above, the World Society of Emergency Surgery
(WSES) promoted an international consensus confer-
ence on monitoring and management of severe adult
TBI polytrauma patients during the first 24 hours after
injury.
Methods
A modified Delphi approach was adopted. Three subse-
quent online questionnaires were administered between
January and May 2019. The agreed cut-off for the con-
sensus was defined as 70% of experts in agreement, in
keeping with recent initiatives in this field [14, 15]. Forty
experts (emergency surgeons, neurosurgeons, and inten-
sivists) in the management of severe TBI patients with
polytrauma [Abbreviated Injury Score (AIS) ≥ 3 at least
in 2 body regions] participated in the consensus process
(see Appendix 1 in Additional file 1). Consensus state-
ments were developed by 3 authors (EP, NS, and FC)
based on a non-systematic literature search and evalu-
ated by the expert panel through an electronic consult-
ation. Sixteen recommendations related to monitoring
and management of adult severe TBI patients with poly-
trauma in the acute phase (first 24 hours) were gener-
ated. Once a consensus (> 70% agreement) for each
statement was achieved, a summary guideline, together
with a corresponding algorithm, was circulated to all
participants for the final acceptance. A summary of the
data was presented and discussed at the 6th Inter-
national WSES meeting held in Nijmegen (The
Netherlands) from 26 to 28 June 2019. The present
paper was drafted after the meeting and distributed to
all participants for review and final approval before
submission.
Notes on the use of the current consensus
The aim of this consensus is to support clinician’s
decision-making in the management of bleeding TBI
polytrauma patients in the first 24 hours after injury.
The included statements are created to assist the physi-
cian’s clinical judgment, which is necessary to provide
appropriate (personalized) therapy. Advanced neuromo-
nitoring and specific management strategies that can be
indicated in a later stage are not addressed. Considering
the lack of high-quality studies in this setting, we
adopted a modified Delphi approach involving experts
from different countries worldwide; this approach is
probably less rigorous than evidence-based guidelines
[13]. However, we think that our methodology can pro-
vide useful recommendations in this challenging clinical
scenario.
The practice guidelines promulgated in this work do
not represent a standard of practice. They are suggested
plans of care, based on best available evidence and the
consensus of experts, but they do not exclude other
approaches as being within the standard of practice.
However, responsibility for the results of treatment rests
with those who are directly engaged therein, and not
with the consensus group.
Results
Agreement was reached on sixteen recommendations
(Table 1); they are listed below with the percentage of
agreement and associated comments. Figure 1 shows the
consensus algorithm.
Recommendation 1
All exsanguinating patients (life-threatening hemorrhage)
require immediate intervention (surgery and/or interven-
tional radiology) for bleeding control.
Agreement: 100%.
Recommendation 2
Patients without life-threatening hemorrhage or follow-
ing measures to obtain bleeding control (in case of life-
threatening hemorrhage) require urgent neurological
evaluation [pupils + Glasgow Coma Scale (GCS) motor
score (if feasible), and brain computed tomography (CT)
scan] to determine the severity of brain damage (life-
threatening or not).
Agreement: 100%.
Recommendation 3
After control of life-threatening hemorrhage is estab-
lished, all salvageable patients with life-threatening brain
lesions require urgent neurosurgical consultation and
intervention.
Agreement: 100%.
Recommendation 4
Patients (without or after control of life-threatening
hemorrhage) at risk for intracranial hypertension (IH)*
(without a life-threatening intracranial mass lesion or
after emergency neurosurgery) require intracranial
pressure (ICP) monitoring regardless of the need of
emergency extra-cranial surgery (EES) [16, 17].
* = patients in coma with radiological signs of IH.
Agreement: 97.5%.
Recommendation 5
We recommend maintaining systolic blood pressure (SBP)
> 100mmHg or mean arterial pressure (MAP) > 80mmHg
during interventions for life-threatening hemorrhage or
emergency neurosurgery. In cases of difficult intraoperative
bleeding control, lower values may be tolerated for the
shortest possible time.
Agreement: 82.5%.
Picetti et al. World Journal of Emergency Surgery           (2019) 14:53 Page 2 of 9
Recommendation 6
We recommend red blood cell (RBC) transfusion for
hemoglobin (Hb) level < 7 g/dl during interventions for
life-threatening hemorrhage or emergency neurosurgery.
Higher threshold for RBC transfusions may be used in pa-
tients “at risk” (i.e. the elderly and/or patients with limited
cardiovascular reserve due to pre-existing heart disease).
Agreement: 97.5 %.
Table 1 Summary of consensus conference recommendations
Number Recommendation Agreement (%)
1 All exsanguinating patients (life-threatening hemorrhage) require immediate intervention
(surgery and/or interventional radiology) for bleeding control.
100
2 Patients without life-threatening hemorrhage or following measures to obtain bleeding
control (in case of life-threatening hemorrhage) require urgent neurological evaluation
[pupils + Glasgow Coma Scale motor score (if feasible), and brain computed tomography
(CT) scan] to determine the severity of brain damage (life-threatening or not).
100
3 After control of life-threatening hemorrhage is established, all salvageable patients with
life-threatening brain lesions require urgent neurosurgical consultation and intervention.
100
4 Patients (without or after control of life-threatening hemorrhage) at risk for intracranial
hypertension (IH)* (without a life-threatening intracranial mass lesion or after emergency
neurosurgery) require intracranial pressure (ICP) monitoring regardless of the need of
emergency extra-cranial surgery (EES) [16, 17].
97.5
5 We recommend maintaining systolic blood pressure (SBP) > 100mmHg or mean arterial
pressure (MAP) > 80 mmHg during interventions for life-threatening hemorrhage or
emergency neurosurgery. In cases of difficult intraoperative bleeding control, lower value
may be tolerated for the shortest possible time.
82.5
6 We recommend red blood cell (RBC) transfusion for hemoglobin (Hb) level < 7 g/dl during
interventions for life-threatening hemorrhage or emergency neurosurgery. Higher threshold
for RBC transfusions may be used in patients “at risk” (i.e., the elderly and/or patients with
limited cardiovascular reserve due to pre-existing heart disease).
97.5
7 We recommend maintaining an arterial partial pressure of oxygen (PaO2) level between
60 and 100mmHg during interventions for life-threatening hemorrhage or emergency
neurosurgery.
95
8 We recommend maintaining an arterial partial pressure of carbon dioxide (PaCO2) level
between 35 and 40 mmHg during interventions for life-threatening hemorrhage or
emergency neurosurgery.
97.5
9 In cases of cerebral herniation, awaiting or during emergency neurosurgery, we recommend
the use of osmotherapy and/or hypocapnia (temporarily).
90
10 In cases requiring intervention for life-threatening systemic hemorrhage, we recommend, at
a minimum, the maintenance of a platelet (PLT) count > 50.000/mm3. In cases requiring
emergency neurosurgery (including ICP probe insertion), a higher value is advisable.
100
11 We recommend maintaining a prothrombin time (PT)/activated partial thromboplastin time
(aPTT) value of < 1.5 normal control during interventions for life-threatening hemorrhage or
emergency neurosurgery (including ICP probe insertion).
92.5
12 We recommend, if available, that Point-of-Care (POC) tests [e.g., thromboelastography (TEG)
and rotational thromboelastometry ROTEM] be utilized to assess and optimize coagulation
function during interventions for life-threatening hemorrhage or emergency neurosurgery
(including ICP probe insertion).
90
13 During massive transfusion protocol initiation, we recommend the transfusion of RBCs/plasma
/PLTs at a ratio of 1/1/1. Afterwards, this ratio may be modified according to laboratory values.
92.5
14 We recommend maintaining a cerebral perfusion pressure (CPP) ≥ 60 mmHg when ICP
monitoring becomes available. This value should be adjusted (individualized) based on
neuromonitoring data and the cerebral autoregulation status of the individual patient.
95
15 In the absence of possibilities to target the underlying pathophysiologic mechanism of IH,
we recommend a stepwise approach [18], where the level of therapy, in patients with elevated
ICP, is increased step by step, reserving more aggressive interventions, which are generally
associated with greater risks/adverse effects, for situations when no response is observed.
97.5
16 We recommend the development of protocols, in conjunction with local resources and practices,
to encourage the implementation of a simultaneous multisystem surgery (SMS) [including
radiologic interventional procedures] in patients requiring both intervention for life-threatening
hemorrhage and emergency neurosurgery for life-threatening brain damage.
100
*Patients in coma with radiological signs of intracranial hypertension
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Recommendation 7
We recommend maintaining an arterial partial pressure
of oxygen (PaO2) level between 60 and 100 mmHg
during interventions for life-threatening hemorrhage or
emergency neurosurgery.
Agreement: 95%.
Fig. 1 Consensus algorithm. (1) Lower values could be tolerated, for the shortest possible time, in case of difficult intraoperative bleeding control.
(2) Higher threshold could be used in patients “at risk” (i.e., elderly and/or with limited cardiovascular reserve because of pre-existing heart
disease). (3) Lower values, temporarily, only in case of impending cerebral herniation. (4) Afterwards, this ratio can be modified according to
laboratory values. (5) Not only in case of impending cerebral herniation but also for cerebral edema control. (6) This value should be adjusted
(individualized) considering neuromonitoring data and cerebral autoregulation status. (7) This approach is recommended in the absence of
possibilities to target the underlying pathophysiologic mechanism of IH. Abbreviations: SMS = systemic multisystem surgery (including radiologic
interventional procedures), CT = computed tomography, GCS = Glasgow Coma Scale (mot = motor part of GCS), MAP = mean arterial pressure,
SBP = systolic blood pressure, Hb = hemoglobin, PaO2 = arterial partial pressure of oxygen, PaCO2 = arterial partial pressure of carbon dioxide,
RBC = red blood cell, P = plasma, PLT = platelet, PT = prothrombin time, aPTT = activated partial thromboplastin time, TEG =
thromboelastography, ROTEM = rotational thromboelastometry, ICP = intracranial pressure, CPP = cerebral perfusion pressure, IH = intracranial
hypertension, EES extracranial emergency surgery
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Recommendation 8
We recommend maintaining an arterial partial pressure of
carbon dioxide (PaCO2) level between 35 and 40mmHg
during interventions for life-threatening hemorrhage or
emergency neurosurgery.
Agreement: 97.5%.
Recommendation 9
In cases of cerebral herniation, awaiting or during emer-
gency neurosurgery, we recommend the use of osmother-
apy and/or hypocapnia (temporarily).
Agreement: 90%.
Recommendation 10
In cases requiring intervention for life-threatening sys-
temic hemorrhage, we recommend, at a minimum, the
maintenance of a platelet (PLT) count > 50.000/mm3. In
cases requiring emergency neurosurgery (including ICP
probe insertion), a higher value is advisable.
Agreement: 100%.
Recommendation 11
We recommend maintaining a prothrombin time (PT)/
activated partial thromboplastin time (aPTT) value of <
1.5 normal control during interventions for life-
threatening hemorrhage or emergency neurosurgery (in-
cluding ICP probe insertion).
Agreement: 92.5%.
Recommendation 12
We recommend, if available, that point-of-care (POC) tests
[e.g., thromboelastography (TEG) and rotational thromboe-
lastometry ROTEM] be utilized to assess and optimize co-
agulation function during interventions for life-threatening
hemorrhage or emergency neurosurgery (including ICP
probe insertion).
Agreement: 90%.
Recommendation 13
During massive transfusion protocol initiation, we rec-
ommend the transfusion of RBCs/Plasma/PLTs at a ratio
of 1/1/1. Afterwards, this ratio may be modified accord-
ing to laboratory values.
Agreement: 92.5%.
Recommendation 14
We recommend maintaining a cerebral perfusion pres-
sure (CPP) ≥ 60mmHg when ICP monitoring becomes
available. This value should be adjusted (individualized)
based on neuromonitoring data and the cerebral auto-
regulation status of the individual patient.
Agreement: 95%.
Recommendation 15
In the absence of possibilities to target the underlying
pathophysiologic mechanism of IH, we recommend a
stepwise approach [18], where the level of therapy, in
patients with elevated ICP, is increased step by step,
reserving more aggressive interventions, which are
generally associated with greater risks/adverse effects, for
situations when no response is observed.
Agreement: 97.5%.
Recommendation 16
We recommend the development of protocols, in conjunc-
tion with local resources and practices, to encourage the im-
plementation of a simultaneous multisystem surgery (SMS)
[including radiologic interventional procedures] in patients
requiring both intervention for life-threatening hemorrhage
and emergency neurosurgery for life-threatening brain
damage.
Agreement: 100%.
Discussion
Critical clinical decisions regarding hemorrhage control in
TBI polytrauma patients
Life-threatening hemorrhage is one of the major prevent-
able causes of early death after trauma [3–5]. Therefore,
precise and early control of hemorrhage, with associated
restoration of circulating blood volume, remains a priority
[9, 19, 20]. It is well accepted that hemorrhage can be con-
trolled by damage control surgery and/or interventional
radiology [8, 21]. Typically, a basic clinical neurological
evaluation (GCS motor score + pupils) with a brain CT
scan is necessary both to determine the patient’s salvage-
ability and to address the possible need for additional moni-
toring and urgent neurosurgical intervention [13, 19, 22].
Often, uncontrolled hemorrhage in TBI polytrauma
patients may require simultaneous multisystem surgery
[23–25]. The main objective should be the control of bleed-
ing and the avoidance/minimization of secondary brain in-
sults. This approach, frequently adopted in the war trauma
setting, but rarely in the civilian one, requires established
protocols and a strict collaboration between different surgi-
cal teams (including interventional radiologists) [23].
Kinoshita et al. performed a retrospective study to evaluate
the efficacy of a hybrid emergency room (capable of deploy-
ing SMS) on functional outcomes in TBI polytrauma
patients [24]. This system was significantly associated with
both shorter times to initiate CT scanning/emergency
surgery and fewer unfavorable outcomes at 6months post-
injury. The results of a recent survey [12] showed that,
although few centers are currently equipped to perform
SMS for hemorrhage in TBI polytrauma patients, the
majority of the responding centers considered the ability to
perform SMS as important, very important, or even
mandatory. Although this consensus reinforces the
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implementation of this approach, future studies designed
to evaluate the usefulness of SMS in polytrauma TBI
patients are warranted.
Preservation/protection of the injured brain during
interventions for extra-cranial bleeding control
In TBI polytrauma patients, it is mandatory to minimize
secondary or delayed insults, like hypoxia and arterial
hypotension, while emergency surgeons control extra-
cranial bleeding. Hypotension (defined as a SBP < 90
mmHg) is a well-recognized secondary insult, known to
be associated with unfavorable neurological outcome
[26, 27]. Moreover, recent observational studies suggest
that the currently established threshold of 90 mmHg
may, in fact, be too low [28, 29]. Further trials are re-
quired to identify the correct SBP value in this setting.
While Brain Trauma Foundation (BTF) guidelines sug-
gest that SBP be maintained at ≥ 100 mmHg for patients
50–69 years or at a minimum of ≥ 110 mmHg for
patients 15–49 years or older than 70 years [13], we have
chosen a value of 100 mmHg as a threshold for bleeding
TBI polytrauma patients. Furthermore, we suggest that
lower values of SBP be maintained for the shortest pos-
sible time, particularly in cases associated with difficult
intraoperative bleeding control.
The optimal Hb value in TBI polytrauma patients re-
mains to be determined. The Transfusion Requirements
in Critical Care (TRICC) study showed no differences in
30-day mortality between the use of a liberal transfusion
strategy (trigger for transfusion Hb > 10 g/dl) and the
use of a more restrictive transfusion strategy (trigger for
transfusion Hb > 7 g/dl) in 838 critically ill patients [30].
A subgroup analysis of the TRICC trial, focusing on 67
severe TBI patients, confirmed no survival benefit com-
paring the liberal vs. the restrictive transfusion strategy
[31]. Robertson et al. [32] reported the results of a ran-
domized clinical trial designed to compare the effects of
erythropoietin and two hemoglobin transfusion thresh-
olds (7 and 10 g/dL) on neurological recovery after TBI.
These investigators found that the administration of
erythropoietin or the maintenance of Hb value > 10 g/dL
was not associated with improved neurological outcome
at 6 months. Moreover, the use of a transfusion thresh-
old of 10 g/dL was associated with a higher incidence of
adverse events. Given the absence of additional pub-
lished studies, we recommend a Hb threshold of 7 g/dl
in TBI polytrauma patients. Higher thresholds for RBCs
transfusions in patients “at risk” (i.e., elderly and/or with
limited cardiovascular reserve because of pre-existing
heart disease) may be considered [30].
Randomized controlled trials targeting the optimal
PaO2 and PaCO2 values in TBI polytrauma patients are
lacking. The presence of hypoxia, historically and patho-
physiologically defined as a peripheral oxygen saturation
(SpO2) < 90% (corresponding near to a PaO2 of 60
mmHg), has been associated with poor outcomes in TBI
patients both in the pre-hospital and in-hospital setting
[27, 33, 34]. A retrospective study, enrolling 3420 severe
TBI patients, showed that both a PaO2 < 110mmHg
and a PaO2 > 487mmHg were associated with increased
mortality and worsened neurological outcomes [35]. An-
other retrospective study, involving 1547 severe TBI pa-
tients, reported (1) an association between early (within
24 hours from admission) hyperoxia (defined as a PaO2
> 200mmHg) and mortality/short-term functional out-
comes (lower GCS discharge scores), and (2) an associ-
ation between a PaO2 < 100mmHg and mortality [36].
The authors suggest that the negative effects of hyperoxia
may have been related to hyperoxia-induced oxygen-free
radical toxicity. However, a transient hyperoxia, achieved
by increasing the oxygen content and delivery, may be po-
tentially beneficial in trauma patients with severe anemia
[37]. Hypocapnia, induced by hyperventilation, is also
known to be associated with the risk of development of
cerebral ischemia [38] and worsened neurological out-
come after TBI [39]. Moreover, in cases of hypovolemia,
an increase in airway pressure (sometimes associated with
hyperventilation) can reduce venous return, thereby
inducing or exacerbating arterial hypotension [40].
Platelets are known to play a key role in hemostasis after
trauma [41]. A reduction in PLT count is associated with
an increase in mortality and the progression of post-
traumatic intracranial bleeding [42–44]. Recent guidelines
recommend the maintenance of a PLT count > 50.000/
mm3 (grade 1 C) in polytrauma patients and further recom-
mend a more stringent cut-off (> 100.000/mm3) in case of
ongoing bleeding and/or TBI (grade 2 C) [10]. Further-
more, coagulopathy is frequently observed after trauma and
is often associated with increased mortality [41, 45]. In TBI
polytrauma patients, coagulopathy is associated with intra-
cranial bleeding progression and unfavorable neurological
outcomes [46, 47].
Massive transfusion is frequently utilized in trauma
patients [19, 20]. The Pragmatic Randomized Optimal
Platelet and Plasma Ratios (PROPPR) study, involving
680 trauma patients with major bleeding, was per-
formed to determine the safety and the effectiveness
of a transfusion strategy involving plasma, PLTs, and
RBCs in a 1:1:1 ratio compared with a 1:1:2 ratio.
This study showed that none of the strategies resulted
in significant differences in mortality. However, more
patients in the 1:1:1 group achieved hemostasis and
fewer experienced death due to exsanguination within
the first 24 hours [48]. Given the negative effects of
coagulopathy on TBI (42–44, 46–47), we recommend
the initiation of a transfusion protocol of RBCs/
plasma/PLTs at a ratio of 1:1:1. This ratio may be
modified afterwards according to laboratory values.
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Point-of-care tests (i.e., TEG, ROTEM, etc.) are in-
creasingly used in the evaluation of coagulation func-
tion in trauma patients with hemorrhagic complications
[10, 20, 41]. These tests can be utilized to obtain a rapid
assessment of hemostasis and to assist in clinical decision-
making; they can further provide critical information
about specific coagulation deficiencies [10, 41, 49]. More-
over, they can be particularly useful in patients taking
novel oral anticoagulants (NOACs) and in the evaluation
of PLT dysfunction induced by trauma and/or drugs [10].
In light of the above, these tests may be useful in TBI
polytrauma patients [50].
Conclusions
Future studies are needed and should be encouraged to
improve clinical outcomes in this challenging setting. In
the absence of more compelling data, the present prac-
tical consensus conference was intended to establish and
provide a shared, multidisciplinary approach to deliver
the best possible care during the very early stages of
management of TBI polytrauma patients.
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